FDA-APPROVED INDICATIONS Type 2 diabetes As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus Limitations of use: has not been studied in patients with a history of pancreatitis TYPE 2 DIABETES RCT SURPASS-2 trial - Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes, NEJM (2021) [PubMed abstract] The SURPASS-2 trial enrolled 1879 adults with type 2 diabetes who were inadequately controlled with metformin at a dose of at least 1500 mg per day Main inclusion criteria Age 18 years T2DM uncontrolled with metformin at 1500 mg/day A1C of 7 - 10.5% BMI 25 and stable for 3 months Main exclusion criteria Type 1 diabetes GFR 50 ng/L
There has been a significant increase in complications associated with diabetes such as heart disorders, stroke, neuropathy, dyslipidemia, metabolic dysfunction-associated steatotic liver disease, and nephropathy
That determination is the provider's call, not the platform's
All participants were subjected to
The HSS A1 Herbal Capsule is engineered to boost metabolism, turning your body into a more efficient calorie-burning machine, crucial for sustainable weight loss
Epithalon peptide Details Epithalon Certificate of Analysis Third-party tested
